<DOC>
	<DOCNO>NCT00543530</DOCNO>
	<brief_summary>Monitor safety tolerability efavirenz oral solution combination Antiretroviral Therapy treatment patient age 3 16 year fail therapy intolerant current therapy . This early phase trial specific protocol information progress publicly available time . ( Full information available trial participant ) .</brief_summary>
	<brief_title>Pediatric Expanded Access Program-Oral Solution ( 0831-908 )</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<criteria>Not tolerate current ART regime laboratory status stable Able take oral liquid medication difficulty swallow capsule Weigh least 10 kg ( 22 lb ) Has 2 episode moderate severe diarrhea vomit last 4 day within 3 month prior take study drug Have take another investigational drug 30 day start study Have history drug alcohol abuse</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>HIV</keyword>
	<keyword>Treatment Experienced</keyword>
</DOC>